Browse the corpus

REFERENCES Ayala RS, Groh BP, Robbins LM, et al, "The Addition of Injectable Lidocaine to Adalimumab Results in Decreased Injection Site Pain and Increased Acceptance of Therapy," 2008, American College of Rheumatology Annual Scientific Meeting, San Francisco, CA (poster). Beukelman T, Patkar NM, Saag KG, et al, "2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features," Arthritis Care Res (Hoboken) , 2011, 63(4):465-82. [PubMed 21452260 ] Biester S, Deuter C, Michels H, et al, "Adalimumab in the Therapy of Uveitis in Childhood," Br J Ophthalmol , 2007, 91(3):319-24. [PubMed 17035274 ] Furst DE, Keystone EC, Kirkham B, et al, "Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic Diseases, 2008," Ann Rheum Dis , 2008, 67 Suppl 3:iii2-25. [PubMed 19022808 ] Lichtenstein GR, Hanauer SB, and Sandborn WJ, "Management of Crohn's Disease in Adults," Am J Gastroenterol , 2009, 104(2):465-83. [PubMed 19174807 ] Lovell DJ, Ruperto N, Goodman S, et al, "Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis," N Engl J Med , 2008, 359(8):810-20. [PubMed 18716298 ] Noe JD and Pfefferkorn M, "Short-Term Response to Adalimumab in Childhood Inflammatory Bowel Disease," Inflamm Bowel Dis , 2008, 14(12):1683-7. [PubMed 18618629 ] Rosh JR, Lerer T, Markowitz J, et al, "Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn's Disease," Am J Gastroenterol , 2009, 104(12):3042-9. [PubMed 19724267 ] Simonini G, Taddio A, Cattalini M, et al, "Prevention of Flare Recurrences in Childhood-Refractory Chronic Uveitis: An Open-Label Comparative Study of Adalimumab Versus Infliximab," Arthritis Care Res (Hoboken) , 2011, 63(4):612-8. [PubMed 21452272 ] Tynjälä P, Kotaniemi K, Lindahl P, et al, "Adalimumab in Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis," Rheumatology (Oxford) , 2008, 47(3):339-44. [PubMed 18238789 ] Viola F, Civitelli F, Di Nardo G, et al, "Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease," Am J Gastroenterol , 2009, 104(10):2566-71. [PubMed 19550415 ]

Tynjälä P, Kotaniemi K, Lindahl P, et al, "Adalimumab in Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis," Rheumatology (Oxford) , 2008, 47(3):339-44. [PubMed 18238789 ] Viola F, Civitelli F, Di Nardo G, et al, "Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease," Am J Gastroenterol , 2009, 104(10):2566-71. [PubMed 19550415 ] Wyneski MJ, Green A, Kay M, et al, "Safety and Efficacy of Adalimumab in Pediatric Patients With Crohn Disease," J Pediatr Gastroenterol Nutr , 2008, 47(1):19-25. [PubMed 18607264 ] Topic 13077 Version 38.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1004-14.112.150.18-587BC34546-S473950.14]